Abstract
Intraurethral instillation was used in place of intracavernosal injection of vasoactive agents for the colour Doppler investigation of patients with erectile dysfunction. A total of 19 patients were enrolled in this study. Colour penile Doppler ultrasonography was done with intracavernosal injection of papaverine-HCl 60 mg and intraurethral instillation of prostaglandin-E2 0.5mg. Arterial diameter, peak systolic velocity and end diastolic velocity were measured before and after papaverine injection and prostaglandin-E2 instillation. Colour penile Doppler parameters increased statistically significantly after papaverine injection and prostaglandin-E2 instillation (p<0.01). But we did not observe differences between the results after papaverine-HCl and prostaglandin-E2. We believe that prostaglandin-E2 may be used with colour Doppler ultrasonography in the evaluation of patients with erectile dysfunction.
Similar content being viewed by others
References
Lue, T. F., Tanagho, E.: Physiology of erection and pharmacological management of impotence.J. Urol., 137, 829 (1987).
Smith, A. D.: Psychologic factors in the multidisciplinary evaluation and treatment of erectile dysfunction.Urol. Clin. North. Am., 15 (1), 41 (1988).
Virag, R.: Intracavernous injection of papaverine for erectile failure.Lancet, 2, 938 (1982).
Wegner, H. E. H., Andersen, R., Knispel, H. H., Banzer, D., Miller, K.: Evaluation of penile arteries with color-coded duplex sonography: Prevalence and possible therapeutic implications of connections between dorsal and cavernous arteries in impotent men.J. Urol., 153, 1469 (1995).
Mueleman, E. J., Diemond, W. L.: Investigation of erectile dysfunction.Urol. Clin. North Am., 22 (4), 803 (1995).
Merckx, L. A., De Bruyne, R. M. G., Goes, E., Derde, M. P., Keuppens, F.: The value of dynamic color duplex scanning in the diagnosis of venogenic impotence.J. Urol., 148, 318 (1992).
Walthauser, M., Schramek, P.: Efficiency and side effects of prostaglandin-E1 in the treatment of erectile dysfunction.J. Urol., 140, 525 (1988).
Gerber, G., Levine, L.: Pharmacological erection program using prostaglandin-E1.J. Urol., 146, 789 (1991).
Van Driel, M. F., Mooibroek, J. J., Van de Wiel, H. B. M., Mensink, H. J. A.: Intracavernous pharmacotherapy: Physiological, sexological and medical and medical aspects.Int. J. Impoten. Res., 3, 95 (1991).
Kim, E. D., El-Rashidy, R., Mc Vary, K.: Papaverine topical gel for treatment of erectile dysfunction.J. Urol., 153, 361 (1995).
Kim, E. D., Mc Vary, K.: Topical prostaglandin-E1 for the treatment of erectile dysfunction.J. Urol., 153, 1828 (1995).
Lazzeri, M., Barbanti, G., Beneforti, P., Turini, D.: Intraurethrally infused capsaicin induced penile erection in humans.Scand. J. Urol. Nephrol. 28, 409, (1994).
Cavellini, G.: Minoxidil versus nitroglycerin: A prospective double-blind controlled trial in transcutaneous erectile facilitation for organic impotence.J. Urol., 146, 50, (1991).
Krane, R., Goldstein, I., Saenz de Tejada, I.: Impotence:N. Engl. J. Med., 321, 1648 (1989).
Vanderschueren, D., Heyrman, R. M., Keogh, E. J., Casey, R. W., Weiske, W. H., Ogrinc, F. G., de Koning Gans, H. J.: A study in patients with erectile dysfunction comparing different formulations of prostaglandin-E1.J. Urol., 154, 1744 (1995).
Chen, J., Godschalk, M. F., Katz, P. G., Mulligan, T.: Incidence of penile pain after injection of a new formulation of prostaglandin-E1.J. Urol., 154, 77 (1995).
Wolfson, B., Pickett, S., Scot, N. E., De Kernion J. B., Rajfer, J.: Intraurethral prostaglandin-E1 cream: A possible alternative treatment for erectile dysfunction.Urology, 42, 73 (1993).
Owen, J., Saunders, F., Harris, C., Fenemore, J., Reid, K., Surridge, D., Condra, M., Morales, A. Topical nitroglycerin: A potential treatment for impotence.J. Urol., 141, 546 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Başar, M., Başar, H., Aydoĝanli, L. et al. Colour penile Doppler ultrasonography with intraurethral prostaglandin-E2: Preliminary results. International Urology and Nephrology 29, 667–671 (1997). https://doi.org/10.1007/BF02552184
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02552184